Page 31 - Pagetit
P. 31

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                   Projects such as the South African Community Epidemiology Network on
                   Drug Use (SACENDU) and its related regional network have been started to
                   address this lack of information.
                     The data in Table 1.3 show that 2.5% of the total global population and
                   3.5% of people 15 years and above had used cannabis at least once in a year
                   between 1998 and 2001. In many developed countries, for example Canada,
                   the USA and European countries, more than 2% of youths reported heroin
                   use and almost 5% reported smoking cocaine in their lifetime. Indeed, 8% of
                   youths in western Europe and more than 20% of those in the USA have
                   reported using at least one type of illicit drug other than cannabis (UNODCCP,
                   2002). There is evidence of rapid increases in the use of amphetamine-type
                   stimulants among teenagers in Asia and Europe. Injecting drug use is also a
                   growing phenomenon, with implications for the spread of HIV infections in
                   an increasing number of countries.
                     The nonmedical use of medications (e.g. benzodiazepines, pain killers,
                   amphetamines, etc.) is known to be fairly common but global statistics are
                   lacking.

                   Adverse effects of psychoactive substances and
                   their mechanisms of action
                   In the majority of cases, people use psychoactive substances because they
                   expect to benefit from their use, whether through the experience of pleasure
                   or the avoidance of pain. The benefit is not necessarily gained directly from
                   the psychoactive action of the substance. Someone drinking beer with
                   colleagues may be more motivated by the feeling of fellowship this brings
                   than by the psychoactive effect of the ethanol.
                   However, the psychoactive effect is nevertheless present, and is usually at
                   least peripherally involved in the decision to use.
                     In spite of the real or apparent benefits, the use of psychoactive substances
                   also carries with it the potential for harm, whether in the short term or long
                   term. Such harm can result from the cumulative amount of psychoactive
                   substance used, for example, the toxic effect of alcohol in producing liver
                   cirrhosis. Harmful effects can also result from the pattern of use, or from the
                   form or medium in which it is taken (see Fig. 1.2). Pattern of use is of obvious
                   importance – for instance, in the case of deaths due to overdose – not only in
                   terms of the amount on a particular occasion, but also in terms of the context
                   of use (e.g. heroin use accompanied by heavy alcohol use). The form or
                   medium of use may also be crucially important. Most of the adverse health
                   effects of tobacco smoking, for instance, come not from the nicotine itself,
                   but from the tars and carbon monoxide which are released when nicotine is
                   taken in cigarette form. Similarly, the adverse effects from taking the drug by
                   injection are evident in the case of heroin use.
                     The main harmful effects due to substance use can be divided into four
                   categories (see Fig. 1.2). First there are the chronic health effects. For alcohol


                                                  10




          Chapter_1                10                              19.1.2004, 11:23
   26   27   28   29   30   31   32   33   34   35   36